Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2020 · 10-Q
Revenue$9.61M$9.61Mno prior Q2 2019 on file Net Income-$1.21M-$1.21MN/M vs Q2 2019 EPS Diluted$0.00$0.00−100.0% vs Q2 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$946,963N/M Free Cash Flowderived-$410,523N/M Margins · derivedGross margin64.1%
Operating margin21.8%
Net margin-12.6%
ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end